These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 1666646)

  • 1. Electron microscopic observation of recombinant Escherichia coli cells overproducing human tumor necrosis factor-alpha mutant as inclusion bodies.
    Moriya H; Kaneko J; Nakamura S; Osumi M
    J Electron Microsc (Tokyo); 1991 Oct; 40(5):364-7. PubMed ID: 1666646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxic and antitumor activity of a recombinant tumor necrosis factor-B1(Fv) fusion protein on LeY antigen-expressing human cancer cells.
    Scherf U; Benhar I; Webber KO; Pastan I; Brinkmann U
    Clin Cancer Res; 1996 Sep; 2(9):1523-31. PubMed ID: 9816329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunocytochemical demonstration of human proinsulin chimeric polypeptide within cytoplasmic inclusion bodies of Escherichia coli.
    Paul DC; Van Frank RM; Muth WL; Ross JW; Williams DC
    Eur J Cell Biol; 1983 Sep; 31(2):171-4. PubMed ID: 6315437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation, solubilization, refolding, and chromatographic purification of human growth hormone from inclusion bodies of Escherichia coli cells: a case study.
    Singh SM; Eshwari AN; Garg LC; Panda AK
    Methods Mol Biol; 2005; 308():163-76. PubMed ID: 16082034
    [No Abstract]   [Full Text] [Related]  

  • 5. Investigation of inclusion body formation in recombinant Escherichia coli with a bioimaging system.
    Li RY; Cheng CY
    J Biosci Bioeng; 2009 May; 107(5):512-5. PubMed ID: 19393549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression, refolding, and characterization of human soluble BAFF synthesized in Escherichia coli.
    Cao P; Mei JJ; Diao ZY; Zhang Sq
    Protein Expr Purif; 2005 May; 41(1):199-206. PubMed ID: 15802238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One-step on-column purification and refolding of a single-chain variable fragment (scFv) antibody against tumour necrosis factor alpha.
    Liu M; Wang X; Yin C; Zhang Z; Lin Q; Zhen Y; Huang H
    Biotechnol Appl Biochem; 2006 Mar; 43(Pt 3):137-45. PubMed ID: 16293104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Turnover of recombinant human hemoglobin in Escherichia coli occurs rapidly for insoluble and slowly for soluble globin.
    Weickert MJ; Curry SR
    Arch Biochem Biophys; 1997 Dec; 348(2):337-46. PubMed ID: 9434746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-level expression, purification, and in vitro refolding of soluble tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).
    Wang D; Shi L
    Appl Biochem Biotechnol; 2009 Apr; 157(1):1-9. PubMed ID: 19306078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and expression in E. coli of the gene for human tumor necrosis factor (h alpha TNF).
    Kłysik J; Konarzewska-Zglińska A; Gałazka G; Uznański B; Okruszek A; Guga P; Wilk A; Koziołkiewicz M; Tchórzewski H; Zembala M
    Arch Immunol Ther Exp (Warsz); 1991; 39(4):349-55. PubMed ID: 1821611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production and purification of recombinant human BLyS mutant from inclusion bodies.
    Xue X; Wang Z; Yan Z; Shi J; Han W; Zhang Y
    Protein Expr Purif; 2005 Jul; 42(1):194-9. PubMed ID: 15886019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Refolding and structural characteristic of TRAIL/Apo2L inclusion bodies from different specific growth rates of recombinant Escherichia coli.
    Kang H; Sun AY; Shen YL; Wei DZ
    Biotechnol Prog; 2007; 23(1):286-92. PubMed ID: 17269700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification and renaturation of recombinant human lymphotoxin (tumour necrosis factor beta) expressed in Escherichia coli as inclusion bodies.
    Jin H; Uddin MS; Huang YL; Teo WK
    J Chem Technol Biotechnol; 1994 Jan; 59(1):67-72. PubMed ID: 7764497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cloning and expression of the cDNA for canine tumor necrosis factor-alpha in E. coli.
    Zucker K; Lu P; Fuller L; Asthana D; Esquenazi V; Miller J
    Lymphokine Cytokine Res; 1994 Jun; 13(3):191-6. PubMed ID: 7948427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The incubation of human blood monocytes with tumor necrosis factor-alpha leads to lysis of tumor necrosis factor-sensitive but not resistant tumor cells.
    Nii A; Fidler IJ
    Lymphokine Res; 1990; 9(2):113-24. PubMed ID: 2338840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal cell division caused by inclusion bodies in E. coli; increased resistance against external stress.
    Lee KK; Jang CS; Yoon JY; Kim SY; Kim TH; Ryu KH; Kim W
    Microbiol Res; 2008; 163(4):394-402. PubMed ID: 18424015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of synthetic human tumor necrosis factor is toxic to Escherichia coli.
    Binepal G; Ranjan RK; Rajagopal K
    Gene; 2012 Feb; 493(1):155-60. PubMed ID: 22143035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clonging, expression and activity determination of the recombinant human soluble B lymphocyte stimulator and its two mutants].
    Chen GY; Zou MJ; Peng SY; Wang JX
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2002 Nov; 34(6):731-6. PubMed ID: 12417915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A genetically engineered fusion protein M4/TNF with increased bifunctional activity refolded in the presence of protein disulfide isomerase.
    Yang J; Raju R; Sharma R; Xiang J
    Hum Antibodies Hybridomas; 1995; 6(4):129-36. PubMed ID: 8688495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High throughput purification of recombinant human growth hormone using radial flow chromatography.
    Singh SM; Sharma A; Panda AK
    Protein Expr Purif; 2009 Nov; 68(1):54-9. PubMed ID: 19500673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.